Taiwan TFDA Medical Device Regulation Overview: Classification, Registration, and Market Approval

Quick answer

What is TFDA's role in Taiwan medical device regulation?

The Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare (MOHW), is the national authority that governs medical devices and in vitro diagnostic (IVD) products under the Medical Devices Act (promulgated 15 January 2020). TFDA sets risk-based classification, issues listing and registration (license) approvals, oversees border inspection, post-market surveillance, and recalls, and maintains public certificate inquiry systems. Class 1 devices generally follow a listing route with annual declaration obligations; Class 2 and 3 devices require a license application with label and instructions for use (IFU) drafts, a business permit copy, and technical documentation submitted by mail or in person to the TFDA counter. Manufacturers and importers must confirm classification under the Regulations Governing Classification of Medical Devices, check for predicate products through TFDA's written inquiry process and the Medical Products/Devices/Cosmetic Certificates Inquiry System, and structure applications according to TFDA's product-splitting rules before placing devices on the Taiwan market.

Who this applies to

This overview applies to:

• Foreign manufacturers exporting medical devices or IVDs to Taiwan
• Taiwan importers and distributors holding or seeking a pharmaceutical/medical device business permit
• Regulatory affairs teams mapping EU MDR, US FDA 510(k)/PMA, or ASEAN AMDD frameworks to Taiwan's Medical Devices Act
• Quality and RA professionals preparing Class 2 or Class 3 license dossiers, or Class 1 listing files

Product scope covers medical devices and IVD products classified under TFDA rules into Class 1, Class 2, and Class 3. If your product falls within the Medical Devices Act definition, assume TFDA oversight applies unless a specific exemption is published on fda.gov.tw. This article is regulatory education—not legal advice. Verify current requirements on TFDA's English and Traditional Chinese portals before submission.

Legal framework: Medical Devices Act and implementing regulations

Taiwan's primary statute is the Medical Devices Act, promulgated on 15 January 2020 and amended on the same date, published on TFDA's law content page. The Act establishes chapters covering listing, registration (licensing), clinical trials, and related obligations for market participants.

TFDA's Medical Devices law and guidance index lists the key implementing regulations that operationalize the Act. Together they form the compliance map for market entry and ongoing obligations:

Additional guidance on TFDA's law index covers good clinical practice (GCP) for device clinical trials. When building a Taiwan regulatory strategy, start with the Medical Devices Act for statutory duties, then drill into the classification and license/listing regulations for procedural detail.

Operating without the correct listing or registration license before marketing creates enforcement risk under the Act and related recall and PMS regulations. Treat unapproved supply as a hard stop—not a post-market cleanup task.

Risk classification: Class 1, Class 2, and Class 3

TFDA applies a three-class risk structure for medical devices, including IVD products, as described in TFDA's registration FAQ and registration guidance pages.

Classification is determined under the Regulations Governing Classification of Medical Devices, which includes annex details mapping product types to class levels. Before filing any application:

1. Identify the product's intended use, anatomical site, and duration of contact (where relevant to annex criteria)
2. Cross-reference the classification annex on fda.gov.tw
3. Document the classification rationale in your internal regulatory file
4. If classification is ambiguous, use TFDA's regulatory consultation channel before committing to a dossier structure (see below)

Misclassification is a common source of query cycles. A Class 2 product filed as Class 1 listing will be rejected and delay market entry.

Listing vs registration vs market approval

Taiwan uses distinct terminology that maps to different approval depths. Understanding the difference prevents filing the wrong route.

Listing is not a shortcut for higher-risk devices. Class 2 and Class 3 products must complete the license application process regardless of reference approvals held in other markets.

Market approval in practice means: valid TFDA listing or license + compliant labeling/IFU + lawful import clearance where applicable. Reference approvals (FDA, CE, PMDA, etc.) may support your technical documentation but do not replace TFDA listing or registration.

For deeper procedural detail on general medical devices, see the related guide on Taiwan medical device registration. For IVD-specific pathways, see Taiwan IVD registration.

Predicate device search workflow

TFDA operates a predicate (same-kind product) system that helps applicants confirm whether a similar device is already approved in Taiwan. This step is critical before drafting a Class 2 or Class 3 dossier, because predicate information informs technical comparison and application strategy.

TFDA provides two official channels per the registration FAQ:

1. Written inquiry process

Submit a formal written inquiry to TFDA requesting confirmation of whether a predicate (same-class, same-intended-use) product exists. This is appropriate when online search results are inconclusive or when you need TFDA's written position before investing in a full dossier.

2. Online certificate inquiry system

Use the Medical Products/Devices/Cosmetic Certificates Inquiry System at:

https://info.fda.gov.tw/MLMS/H0001.aspx

Search by product name, license number, or manufacturer to retrieve publicly listed certificate data for medical devices already approved in Taiwan.

Recommended predicate search workflow:

Step 1 — Draft product description (name, intended use, classification number)
Step 2 — Search MLMS/H0001.aspx for matching licenses
Step 3 — If no clear match, prepare written inquiry to TFDA
Step 4 — Document predicate (or absence) in regulatory strategy memo
Step 5 — Align technical documentation structure to TFDA Class 2/3 requirements
Step 6 — Proceed to application assembly only after classification and predicate are confirmed

Predicate confirmation does not eliminate the need for a full license application for Class 2/3 devices. It informs how you structure comparative technical evidence within your submission.

Class II and Class III application requirements

For Class 2 and Class 3 medical devices, TFDA requires a license application submitted by mail or in person to the TFDA submission counter, per the registration FAQ. Electronic-only submission is not described as the primary route in official FAQ guidance—confirm current intake methods on fda.gov.tw at the time of filing.

Core document set (Class 2/3)

Technical documentation scope should align with the device's classification and intended use. Include design and manufacturing information, risk analysis, clinical or performance evidence as applicable, and standards conformity where relevant. TFDA may issue queries requesting additional data during review.

Application splitting and grouping rules

TFDA's Class 2 and 3 registration guidance page (siteListContent id=46829) sets explicit product-splitting rules that affect how many applications you file:

Models may be combined in one application when ALL of the following match:

• Same classification number
• Same product name
• Same manufacturer
• Same intended use

When these four elements align, multiple models (variants) may be grouped into a single application.

Separate applications are required when:

• Any of the four elements above differs
• The product is a non-exclusive accessory—for example, ultrasound gel or electrodes that are not exclusively bundled with a primary device

TFDA also states that one product name per application is the general principle. Plan your SKU matrix against these rules before printing label drafts—splitting errors force duplicate filings and counter resubmissions.

Regulatory consultation before filing

TFDA's registration FAQ references a regulatory consultation service sponsored through the Center for Drug Evaluation (CDE):

• Hotline: +886-2-8170-6008
• Portal: 6008.cde.org.tw

Use this channel when classification is unclear, predicate status is uncertain, or you need pre-submission guidance on dossier structure. Consultation output should be documented in your regulatory file but does not replace formal TFDA review of a submitted application.

Step-by-step market entry workflow

1. Confirm product scope — Verify the product is a medical device or IVD under the Medical Devices Act; exclude products outside TFDA device definitions.
2. Determine classification — Apply the Regulations Governing Classification of Medical Devices; record classification number and rationale.
3. Search predicate — Query info.fda.gov.tw/MLMS/H0001.aspx; submit written inquiry if needed.
4. Select regulatory route — Class 1 → listing + annual declaration path; Class 2/3 → license application path.
5. Confirm applicant eligibility — Ensure the submitting entity holds a valid business permit and is authorized to import or manufacture.
6. Apply splitting rules — Group models only when classification number, product name, manufacturer, and intended use match; file separate applications for non-exclusive accessories.
7. Prepare dossier — Assemble application form, label/IFU drafts (×2), business permit copy, and technical documentation (Class 2/3).
8. Submit to TFDA counter — Mail or deliver in person to the TFDA submission counter per FAQ guidance.
9. Respond to TFDA queries — Address deficiencies within TFDA's review timeline; update label/IFU drafts if requested.
10. Obtain listing or license — Confirm approval on TFDA certificate records before import and sale.
11. Plan post-market obligations — Implement PMS and recall procedures per TFDA regulations; maintain annual declaration for listed Class 1 products.

Market entry checklist

• Product confirmed as medical device or IVD under Medical Devices Act
• Classification determined under Regulations Governing Classification of Medical Devices
• Classification number and annex reference documented internally
• Predicate search completed on info.fda.gov.tw/MLMS/H0001.aspx
• Written TFDA inquiry submitted if predicate status unclear
• Regulatory route selected: Class 1 listing vs Class 2/3 license
• Applicant business permit current and copied for dossier
• Application splitting reviewed: same classification, name, manufacturer, intended use → models grouped
• Non-exclusive accessories (e.g., gel, electrodes) planned as separate applications
• Application form completed for listing or license route
• Label drafts (×2) and IFU drafts (×2) prepared for Class 2/3
• Technical documentation assembled for Class 2/3 license application
• Submission prepared for mail or in-person delivery to TFDA counter
• Post-market surveillance and recall procedures aligned with TFDA regulations
• Annual declaration calendar set for Class 1 listed products
• Regulatory consultation (+886-2-8170-6008) used if pre-filing questions remain

Common pitfalls

1. Treating listing as registration — Class 2 and Class 3 devices require a license, not a Class 1-style listing. Misrouted applications are rejected.
2. Skipping predicate search — Filing without checking MLMS/H0001.aspx or a written inquiry wastes review cycles when a predicate already exists.
3. Incorrect model grouping — Combining models with different intended uses or manufacturers violates TFDA splitting rules on the Class 2/3 registration page.
4. Bundling non-exclusive accessories — Ultrasound gel, electrodes, and similar non-exclusive accessories need separate applications even when sold with a primary device.
5. Missing business permit copy — TFDA's FAQ lists the business permit copy as a mandatory Class 2/3 attachment; omitting it stops intake.
6. Single label/IFU copy — TFDA requires two copies each of label and IFU drafts for Class 2/3 applications.
7. Ignoring annual declaration for Class 1 — Listing approval carries annual declaration obligations under the license/listing regulations; missed declarations create compliance gaps.
8. Assuming foreign approval substitutes for TFDA — FDA 510(k), CE marking, or other certificates support technical files but do not replace Taiwan listing or license.

FAQ

What is TFDA and what does it regulate?

The Taiwan Food and Drug Administration (TFDA) is the MOHW agency responsible for medical device and IVD regulation under the Medical Devices Act (promulgated 15 January 2020). TFDA oversees classification, listing, registration licensing, border inspection, post-market surveillance, and recalls for devices placed on the Taiwan market.

How are medical devices classified in Taiwan?

TFDA classifies devices into Class 1, Class 2, and Class 3 under the Regulations Governing Classification of Medical Devices, including IVD products. Class 1 represents lowest risk (listing route); Class 2 and Class 3 require license registration with progressively stringent controls. Classification annex details are published on fda.gov.tw.

What is the difference between listing and registration in Taiwan?

Listing (登錄) applies primarily to Class 1 devices and includes annual declaration obligations. Registration (查驗登記) applies to Class 2 and Class 3 devices and results in a medical device license after TFDA review of a full application dossier. Both routes are required before lawful marketing—reference foreign approvals alone are insufficient.

How do I find a predicate device in Taiwan?

Search the Medical Products/Devices/Cosmetic Certificates Inquiry System at info.fda.gov.tw/MLMS/H0001.aspx for existing TFDA-approved products with similar classification and intended use. If results are unclear, submit a written inquiry to TFDA per the registration FAQ before preparing your license application.

What documents are required for Class II medical device registration?

Class 2 (and Class 3) applications require: the application form, two copies each of label and IFU drafts, a copy of the business permit, and technical documentation. Submit by mail or in person to the TFDA counter per official FAQ guidance.

Who can submit applications to TFDA?

Applicants must hold a valid pharmaceutical/medical device business permit and submit as the permitted entity—typically a Taiwan importer, distributor, or manufacturer. Foreign manufacturers generally work through a permitted local entity. Confirm current applicant eligibility requirements on fda.gov.tw before filing.

Official sources

• Medical Devices Act (promulgated 2020-01-15): https://www.fda.gov.tw/ENG/lawContent.aspx?id=3352
• Medical Devices law and guidance index: https://www.fda.gov.tw/eng/law.aspx?cr=605905758
• Class 2 and 3 registration — application splitting rules: https://www.fda.gov.tw/ENG/siteListContent.aspx?id=46829
• TFDA registration FAQ (classification, predicate, submission): https://www.fda.gov.tw/tc/includes/GetFile.ashx?id=f637975617521679686
• Medical Products/Devices/Cosmetic Certificates Inquiry System: https://info.fda.gov.tw/MLMS/H0001.aspx
• Regulatory consultation hotline: +886-2-8170-6008 | 6008.cde.org.tw